Fujifilm Holdings Corp 4901.T said on Friday it had applied for approval in Japan of its anti-influenza drug Avigan as a treatment for COVID-19.
The company had said in September a late-stage study of Avigan had shown reduced recovery times for COVID-19 patients with non-severe symptoms and it would seek to file for approval as early as this month.
Why Europe’s drug shortages may get worse | Reuter Most European countries reporting shortages of antibiotics...
Mexican police detained a medical doctor and two others on Tuesday, all implicated in causing a...
Nurses, doctors, and respiratory therapist prepare to intubate a coronavirus disease (COVID-19) patient as the Omicron...
Largest ever strikes by health workers Government urges workers to call off walkouts, People should continue...
India will spend $79.6 million on strengthening its drug regulatory system, the health minister said on...
